Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin LymphomaPaolo Strati, Shabnum Patel, Loretta Nastoupil, et al.
Annals of Hematology|November 17, 2017
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasmsPrajwal Boddu, Lucia Masarova, Srdan Verstovsek, et al.
British Journal of Haematology|September 23, 2024
Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label studyPaolo Strati, Rebecca Champion, Morton Coleman, et al.
JACC. Case Reports|July 28, 2021
Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used ImmunotherapyRobin Jacob, Paolo Strati, Nicolas Palaskas, et al.
Blood|February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Blood Advances|June 18, 2024
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS interventionFateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, et al.
Ejhaem|February 2, 2026
Venous Thromboembolism in Aggressive B-Cell Lymphoma Patients Treated with CD19 CAR-T Therapy: Single-Institution StudyNeha Venkatesh, Kevin Milligan, Julia Parrish, et al.
British Journal of Haematology|December 12, 2024
Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open-label study (ACE-LY-003)Paolo Strati, Richy Agajanian, Izidore S Lossos, et al.
Leukemia Research|September 15, 2014
Clinical significance of microcytosis in patients with primary myelofibrosisPaolo Strati, Naveen Pemmaraju, Zeev Estrov, et al.
Haematologica|May 27, 2014
Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletionPaolo Strati, Michael J Keating, Susan M O'Brien, et al.
Pageof 16